Number of Shares
31,251.00
Current Holdings Value*
$2.21 Mil
% of Portfolio
0.15%
Total Estimate Gain
$3.17 Mil
% of Total Estimate Gain
82.20%

LOWE BROCKENBROUGH & CO INC's Novo Nordisk AS Holding Summary

As of 2025-03-31, LOWE BROCKENBROUGH & CO INC held 31,251.00 shares of Novo Nordisk AS(NVO), totaling $2.21 Mil. This investment constitutes 0.15% of their stock portfolio, and LOWE BROCKENBROUGH & CO INC now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2018Q4. And since then LOWE BROCKENBROUGH & CO INC has made 7 purchases of NVO, at an average price of $46.58, for a total of 82,748.00 shares. In addition, there have been 18 sales at an average price of $94.32 for 51,497.00 shares. Based on historical transaction data and NVO's current price of $69.32, LOWE BROCKENBROUGH & CO INC's estimated gain on his NVO holdings is $3.17 Mil, reflecting a 82.20% gain to date.

LOWE BROCKENBROUGH & CO INC NVO ($69.32) Holding Chart

LOWE BROCKENBROUGH & CO INC NVO ($69.32) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1